Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMartinez Garcia, Maria Fernanda
dc.contributor.authorCorrales Insa, Irene
dc.contributor.authorFernández-Caballero, Mariana
dc.contributor.authorRamírez Orihuela, Lorena
dc.contributor.authorCortina Giner, Vicente
dc.contributor.authorComes Fernandez, Natalia
dc.contributor.authorJuarez-Gimenez, Juan Carlos
dc.contributor.authorBenítez Hidalgo, Olga
dc.date.accessioned2023-05-25T07:33:40Z
dc.date.available2023-05-25T07:33:40Z
dc.date.issued2023-05
dc.identifier.citationBenítez Hidalgo O, Martinez Garcia MF, Corrrales Insa I, Fernández-Caballero M, Ramírez Orihuela L, Cortina Giner V, et al. VHrare study: Prevalence, clinical features and management of severe rare bleeding disorders in a large cohort. EJHaem. 2023 May;4(2):476–82.
dc.identifier.issn2688-6146
dc.identifier.urihttps://hdl.handle.net/11351/9616
dc.descriptionBleeding phenotype; Diagnosis; Rare bleeding disorders
dc.description.abstractIntroduction: Rare bleeding disorders (RBD) constitute 5% of total hereditary bleeding disorders, although the number could be higher, due to the presence of undiagnosed asymptomatic patients. The objective of this study was to analyze the prevalence and characteristics of patients with severe RBDs in our area. Material and methods: We analyzed the patients with RBD followed at a tertiary-level hospital between January 2014 and December 2021. Results: A total of 101 patients were analyzed, with a median age at diagnosis of 27.67 years (range 0–89), of which 52.47% were male. The most frequent RBD in our population was FVII deficiency. Regarding the diagnostic reason, the most frequent cause was a preoperative test and only 14.8% reported bleeding symptoms at the time of diagnosis. A genetic study was carried out in 63.36% of patients and the most frequent mutation type found was finding a missense mutation. Conclusions: The distribution of RBDs in our centre is similar to the one reported in the literature. The majority of RBDs were diagnosed from a preoperative test and this allowed preventive treatment prior to invasive procedures to avoid bleeding complications. 83% of patients did not have a pathological bleeding phenotype according to ISTH-BAT
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesEJHaem;4(2)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectMalalties rares
dc.subjectMalalties hemorràgiques - Tractament
dc.subjectMalalties hemorràgiques - Diagnòstic
dc.subject.meshHemorrhagic Disorders
dc.subject.mesh/diagnosis
dc.subject.meshRare Diseases
dc.subject.meshDisease Management
dc.titleVHrare study: Prevalence, clinical features and management of severe rare bleeding disorders in a large cohort
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/jha2.664
dc.subject.decstrastornos hemorrágicos
dc.subject.decs/diagnóstico
dc.subject.decsenfermedades raras
dc.subject.decstratamiento de las enfermedades
dc.relation.publishversionhttps://doi.org/10.1002/jha2.664
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Benítez Hidalgo O, Martinez Garcia MF] Servei d’Hematologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Corrrales Insa I, Ramírez Orihuela L, Comes Fernández N] Congenital Coagulopaties, Banc de Sang i Teixits, Barcelona, Spain. Grup de Recerca Medicina Transfusional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Fernández-Caballero M] Laboratory of Haematology, ICO-Badalona, Germans Trias i Pujol University Hospital, Institut Josep Carreras Contra la Leucemia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Cortina Giner V] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Juarez Gimenez JC] Servei de Farmàcia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid37206292
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record